BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24535158)

  • 1. Nuclear-cytoplasmic PARP-1 expression as an unfavorable prognostic marker in lymph node‑negative early breast cancer: 15-year follow-up.
    Donizy P; Pietrzyk G; Halon A; Kozyra C; Gansukh T; Lage H; Surowiak P; Matkowski R
    Oncol Rep; 2014 Apr; 31(4):1777-87. PubMed ID: 24535158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nuclear expression of poly (ADP-ribose) polymerase-1 (PARP1) in invasive primary breast tumors is associated with chemotherapy sensitivity.
    Zhai L; Li S; Li X; Li H; Gu F; Guo X; Liu F; Zhang X; Fu L
    Pathol Res Pract; 2015 Feb; 211(2):130-7. PubMed ID: 25480692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear PARP-1 protein overexpression is associated with poor overall survival in early breast cancer.
    Rojo F; García-Parra J; Zazo S; Tusquets I; Ferrer-Lozano J; Menendez S; Eroles P; Chamizo C; Servitja S; Ramírez-Merino N; Lobo F; Bellosillo B; Corominas JM; Yelamos J; Serrano S; Lluch A; Rovira A; Albanell J
    Ann Oncol; 2012 May; 23(5):1156-1164. PubMed ID: 21908496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated nuclear S100P expression is associated with poor survival in early breast cancer patients.
    Maciejczyk A; Łacko A; Ekiert M; Jagoda E; Wysocka T; Matkowski R; Hałoń A; Györffy B; Lage H; Surowiak P
    Histol Histopathol; 2013 Apr; 28(4):513-24. PubMed ID: 23364898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced nuclear expression of transcription factor AP-2 associates with aggressive breast cancer.
    Pellikainen J; Kataja V; Ropponen K; Kellokoski J; Pietiläinen T; Böhm J; Eskelinen M; Kosma VM
    Clin Cancer Res; 2002 Nov; 8(11):3487-95. PubMed ID: 12429639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LETM1 overexpression is correlated with the clinical features and survival outcome of breast cancer.
    Li N; Zheng Y; Xuan C; Lin Z; Piao L; Liu S
    Int J Clin Exp Pathol; 2015; 8(10):12893-900. PubMed ID: 26722481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of HOXD13 expression in human breast cancer.
    Zhong ZB; Shan M; Qian C; Liu T; Shi QY; Wang J; Liu Y; Liu Y; Huang YX; Pang D
    Int J Clin Exp Pathol; 2015; 8(9):11407-13. PubMed ID: 26617867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear PARP1 expression and its prognostic significance in breast cancer patients.
    Mazzotta A; Partipilo G; De Summa S; Giotta F; Simone G; Mangia A
    Tumour Biol; 2016 May; 37(5):6143-53. PubMed ID: 26614429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and biological significance of RAD51 expression in breast cancer: a key DNA damage response protein.
    Alshareeda AT; Negm OH; Aleskandarany MA; Green AR; Nolan C; TigHhe PJ; Madhusudan S; Ellis IO; Rakha EA
    Breast Cancer Res Treat; 2016 Aug; 159(1):41-53. PubMed ID: 27464795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cytoplasmic expression of aquaporin-1 in breast cancer cells and its relationship with clinicopathological characteristics and prognosis].
    Zhang B; Liu FF; Ma YJ; Gu F
    Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):904-9. PubMed ID: 24506959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological significance and prognostic value of CD133 expression in triple-negative breast carcinoma.
    Zhao P; Lu Y; Jiang X; Li X
    Cancer Sci; 2011 May; 102(5):1107-11. PubMed ID: 21276138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoplasmic poly(adenosine diphosphate-ribose) polymerase expression is predictive and prognostic in patients with breast cancer treated with neoadjuvant chemotherapy.
    von Minckwitz G; Müller BM; Loibl S; Budczies J; Hanusch C; Darb-Esfahani S; Hilfrich J; Weiss E; Huober J; Blohmer JU; du Bois A; Zahm DM; Khandan F; Hoffmann G; Gerber B; Eidtmann H; Fend F; Dietel M; Mehta K; Denkert C
    J Clin Oncol; 2011 Jun; 29(16):2150-7. PubMed ID: 21519019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The microRNA maturation regulator Drosha is an independent predictor of outcome in breast cancer patients.
    Khoshnaw SM; Rakha EA; Abdel-Fatah T; Nolan CC; Hodi Z; Macmillan RD; Ellis IO; Green AR
    Breast Cancer Res Treat; 2013 Jan; 137(1):139-53. PubMed ID: 23225145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Relation of Parafibromin Expression with Clinicopathological Factors in Invasive Breast Carcinomas.
    Karaarslan S; Genç B; Nart A; Börekçi İ; Buğdayci MH
    Turk Patoloji Derg; 2016; 32(1):8-14. PubMed ID: 26832176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of MAGE-A9 predicts unfavorable outcome in breast cancer.
    Xu X; Tang X; Lu M; Tang Q; Zhang H; Zhu H; Xu N; Zhang D; Xiong L; Mao Y; Zhu J
    Exp Mol Pathol; 2014 Dec; 97(3):579-84. PubMed ID: 25445503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of fibroblastic growth factor receptor 2 is correlated with poor prognosis in patients with breast cancer.
    Sun S; Jiang Y; Zhang G; Song H; Zhang X; Zhang Y; Liang X; Sun Q; Pang D
    J Surg Oncol; 2012 Jun; 105(8):773-9. PubMed ID: 22006548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biologic role of activated leukocyte cell adhesion molecule overexpression in breast cancer cell lines and clinical tumor tissue.
    Hein S; Müller V; Köhler N; Wikman H; Krenkel S; Streichert T; Schweizer M; Riethdorf S; Assmann V; Ihnen M; Beck K; Issa R; Jänicke F; Pantel K; Milde-Langosch K
    Breast Cancer Res Treat; 2011 Sep; 129(2):347-60. PubMed ID: 20972617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of CD44 and CD24 for prognosis and chemotherapy response in invasive breast ductal carcinoma.
    Chen Y; Song J; Jiang Y; Yu C; Ma Z
    Int J Clin Exp Pathol; 2015; 8(9):11287-95. PubMed ID: 26617852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological and clinical significance of PARP1 protein expression in breast cancer.
    Green AR; Caracappa D; Benhasouna AA; Alshareeda A; Nolan CC; Macmillan RD; Madhusudan S; Ellis IO; Rakha EA
    Breast Cancer Res Treat; 2015 Jan; 149(2):353-62. PubMed ID: 25528020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preserved Axin expression is associated with an aggressive phenotype in invasive breast carcinomas.
    Irini T; Paraskevi A; Ioanna G; Christos P; Lydia N
    APMIS; 2013 Sep; 121(9):797-805. PubMed ID: 23278310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.